Activated PI3K also promotes the triggering of the AKT pathway, which plays a key role in tumor cell survival, given its capability in inactivating the BAD (BCL2-associated agonist of cell death) protein and GSK3β, as well as stabilizing β-catenin with the promotion of gene transcription and proliferation. The gene discussed is AKT1; the disease is neoplasm.